Change Tracker · updated every CMS quarter

CMS ASP Pricing File — July 2026: What Changed

The July 2026 ASP pricing file — officially the Medicare Part B Drug Payment Limit File — resets the payment limit on every provider-administered drug. This page ranks every change — all 690 of them — so a practice that buys and bills can see which limits moved before the EOBs do. Tracked quarterly against the primary CMS file since Q1 2005.

Preliminary fileSource: CMS July 2026 file, posted June 4, 2026Limits effective July 1, 2026vs. the April 2026 file as publishedAll CMS files + NOC & crosswalk companions

Limits changed: 690
Biggest decrease: -89.1%J3489 · Zoledronic acid 1mg
Biggest increase: +398.6%J1740 · Ibandronate sodium injection
Median change: +1.2%143 codes moved ≥10%
New codes: 10
Deleted codes: 8

This quarter’s story

The headline of the July file is zoledronic acid (J3489) losing 89% of its payment limit — a generic price war finally reaching the ASP basis — while ibandronate (J1740) moves the other way, up nearly 400%. Biosimilar repricing keeps rolling: bevacizumab-adcd (Vegzelma, Q5129) drops another 32% on the heels of last quarter’s ustekinumab collapse, and ranibizumab-nuna (Byooviz, Q5124) snaps upward 240% — biosimilar ASPs move violently in both directions while volumes settle.

If your practice stocks bone agents or retina biosimilars, this quarter changes your acquisition math before it changes your contracts.

Largest payment-limit decreases

A falling limit on a drug you stock compresses margin until your acquisition cost catches down. Top 30 by percent, Q2 2026 → Q3 2026 — the full list of all 690 changes is below.

HCPCS	Drug	Was ($/unit)		Now ($/unit)	Change
J3489	Zoledronic acid 1mg	30.878	→	3.361	-89.1%
J1811	Fiasp for insulin pump use	8.763	→	1.727	-80.3%
J1813	Lyumjev for insulin pump use	15.104	→	4.802	-68.2%
J1160	Digoxin injection	10.372	→	3.911	-62.3%
J1301	Injection, edaravone, 1 mg	15.178	→	6.463	-57.4%
Q5138	Inj, wezlana, iv, 1 mg	4.544	→	2.354	-48.2%
J9294	Inj pemetrexed, hospira 10mg	5.198	→	2.943	-43.4%
J7520	Sirolimus, oral	1.266	→	0.744	-41.2%
J1932	Inj, lanreotide, (cipla) 1mg	32.19	→	20.33	-36.8%
Q9965	Locm 100-199mg/ml iodine,1ml	1.155	→	0.75	-35.1%
J3000	Streptomycin injection	40.256	→	26.883	-33.2%
Q5129	Inj, vegzelma, 10 mg	34.654	→	23.647	-31.8%
J0650	Inj, levothyroxine nos 10mcg	7.411	→	5.096	-31.2%
Q5112	Inj ontruzant 10 mg	29.808	→	20.989	-29.6%
J2175	Meperidine hydrochl /100 mg	8.817	→	6.339	-28.1%
J9075	Inj, cyclophosphamide, nos	0.773	→	0.575	-25.6%
J0875	Injection, dalbavancin	15.003	→	11.293	-24.7%
J2778	Ranibizumab injection	67.853	→	51.09	-24.7%
J0132	Acetylcysteine injection	0.511	→	0.389	-23.9%
J1612	Inj glucagon (gvoke) 0.01 mg	2.365	→	1.799	-23.9%
J9293	Mitoxantrone hydrochl / 5 mg	38.614	→	29.702	-23.1%
J2267	Inj, mirikizumab-mrkz, 1 mg	42.092	→	32.658	-22.4%
J9179	Eribulin mesylate injection	76.756	→	59.979	-21.9%
J9017	Arsenic trioxide injection	6.445	→	5.069	-21.3%
J0360	Hydralazine hcl injection	4.288	→	3.395	-20.8%
J0166	Inj epinephrine (bpi)	0.836	→	0.669	-20.0%
J1610	Glucagon hydrochloride/1 mg	146.332	→	117.331	-19.8%
J0637	Caspofungin acetate	3.575	→	2.879	-19.5%
J3360	Diazepam injection	8.508	→	6.854	-19.4%
J0476	Baclofen intrathecal trial	54.338	→	43.84	-19.3%

Stock any of these? The practice X-Ray prices this quarter’s file against your actual drug mix and payer book.

Largest payment-limit increases

Rising limits restore headroom — or signal a market reset after a shortage or relaunch.

HCPCS	Drug	Was ($/unit)		Now ($/unit)	Change
J1740	Ibandronate sodium injection	9.057	→	45.154	+398.6%
Q5124	Inj. byooviz, 0.1 mg	70.904	→	240.972	+239.9%
J9297	Inj pemetrexed (sandoz) 10mg	1.459	→	4.879	+234.4%
J1645	Dalteparin sodium	15.863	→	48.413	+205.2%
J0744	Ciprofloxacin iv	0.755	→	1.72	+127.8%
J1364	Erythro lactobionate /500 mg	91.226	→	172.479	+89.1%
Q9997	Ustekinumab-ttwe iv inj 1 mg	4.531	→	8.552	+88.7%
J2270	Morphine sulfate injection	4.449	→	8.087	+81.8%
J9305	Inj. pemetrexed nos 10mg	4.038	→	6.952	+72.2%
J0595	Butorphanol tartrate 1 mg	6.146	→	10.508	+71.0%
J1205	Chlorothiazide sodium inj	46.921	→	77.771	+65.7%
Q2050	Doxorubicin inj 10mg	71.861	→	116.605	+62.3%
J7682	Tobramycin non-comp unit	7.766	→	12.305	+58.4%
J1450	Fluconazole	3.874	→	6.105	+57.6%
J2274	Inj morphine pf epid ithc	12.149	→	18.914	+55.7%
J0594	Busulfan injection	0.677	→	1.033	+52.6%
J9040	Bleomycin sulfate injection	16.598	→	24.838	+49.6%
J1643	Inj heparin, pfizer, 1000u	1.146	→	1.711	+49.3%
J9027	Clofarabine injection	10.937	→	16.245	+48.5%
J2060	Lorazepam injection	1.66	→	2.302	+38.7%
J2690	Procainamide hcl injection	214.811	→	295.361	+37.5%
J9033	Inj, bendamustine hcl, 1mg	2.159	→	2.96	+37.1%
J9049	Inj, bortezomib, hospira	1.259	→	1.712	+36.0%
J0167	Inj epinephrine (hospira)	1.082	→	1.422	+31.4%
J9351	Topotecan injection	2.111	→	2.759	+30.7%
J8501	Oral aprepitant	2.389	→	3.069	+28.5%
J2021	Inj, linezolid (hospira)	26.834	→	34.175	+27.4%
J1265	Dopamine injection	0.801	→	1.012	+26.3%
J2300	Inj nalbuphine hydrochloride	3.421	→	4.287	+25.3%
Q5116	Inj., trazimera, 10 mg	10.425	→	13.033	+25.0%

Biggest dollar moves on high-cost drugs

Percent rankings favor cheap drugs. This view ranks drugs with a payment limit of $100+/unit by absolute $/unit movement — the lens a CFO reads first.

HCPCS	Drug	Was ($/unit)		Now ($/unit)	Δ $/unit	Δ %
Q2057	Afamitresgene autoleucel	770,620.00	→	813,967.375	+43,347.375	+5.6%
Q2041	Axicabtagene ciloleucel car+	531,849.118	→	562,500.892	+30,651.774	+5.8%
Q2053	Brexucabtagene car pos t	489,290.601	→	510,103.919	+20,813.318	+4.3%
Q2054	Lisocabtagene mara car pos t	562,260.836	→	579,570.614	+17,309.778	+3.1%
Q2055	Idecabtagene vicleucel car	559,781.081	→	567,977.78	+8,196.699	+1.5%
J9226	Supprelin la implant	41,173.427	→	37,491.974	−3,681.453	-8.9%
Q2042	Tisagenlecleucel car-pos t	614,180.808	→	611,693.171	−2,487.637	-0.4%
J9266	Pegaspargase injection	28,424.059	→	29,663.965	+1,239.906	+4.4%
J3402	Inj. remestemcel-l-rknd/ td	202,713.584	→	203,659.763	+946.179	+0.5%
Q2056	Ciltacabtagene car-pos t	588,494.808	→	587,977.755	−517.053	-0.1%
Q2043	Sipuleucel-t auto cd54+	56,269.192	→	55,932.427	−336.765	-0.6%
J7504	Lymphocyte immune globulin	5,292.432	→	5,548.962	+256.53	+4.8%
J1162	Digoxin immune fab (ovine)	5,166.991	→	5,383.321	+216.33	+4.2%
J9200	Floxuridine injection	4,250.967	→	4,396.492	+145.525	+3.4%
J2507	Pegloticase injection	3,824.523	→	3,929.337	+104.814	+2.7%
J0202	Injection, alemtuzumab	2,440.415	→	2,544.937	+104.522	+4.3%
J9183	Gemcitabine intravesical sys	73,088.26	→	72,984.241	−104.019	-0.1%
J0802	Inj. (ani), up to 40 units	3,571.351	→	3,674.678	+103.327	+2.9%
J3316	Inj., triptorelin xr 3.75 mg	3,723.756	→	3,819.934	+96.178	+2.6%
J0480	Basiliximab	4,812.313	→	4,905.049	+92.736	+1.9%

Every change in the July 2026 file

All 690changed codes, A–Z — use your browser’s find (Ctrl/Cmd-F) to jump to a code you bill.

Show all 690 changes

HCPCS	Drug	Was	Now	Δ %
A9573	Inj, gadopiclenol, 1 ml	3.22	3.152	-2.1%
A9576	Inj prohance multipack	1.391	1.369	-1.6%
A9577	Inj multihance	1.787	1.791	+0.2%
A9578	Inj multihance multipack	1.717	1.697	-1.2%
A9579	Gad-base mr contrast nos,1ml	1.449	1.435	-1.0%
A9581	Gadoxetate disodium inj	14.727	14.752	+0.2%
A9589	Insti hexaminolevulinate hcl	1,424.121	1,432.336	+0.6%
J0121	Inj., omadacycline, 1 mg	4.134	4.188	+1.3%
J0122	Inj., eravacycline, 1 mg	1.288	1.381	+7.2%
J0129	Abatacept injection	44.718	45.859	+2.6%
J0132	Acetylcysteine injection	0.511	0.389	-23.9%
J0164	Epinephrine in nacl (baxter)	0.924	0.912	-1.3%
J0166	Inj epinephrine (bpi)	0.836	0.669	-20.0%
J0167	Inj epinephrine (hospira)	1.082	1.422	+31.4%
J0168	Epinephrine (intl med sys)	2.876	2.555	-11.2%
J0169	Inj epinephrine (adrenalin)	0.869	0.783	-9.9%
J0174	Inj, lecanemab-irmb, 1 mg	1.336	1.342	+0.4%
J0175	Inj, donanemab-azbt, 2 mg	4.14	4.165	+0.6%
J0177	Inj, aflibercept hd, 1 mg	301.177	298.683	-0.8%
J0178	Aflibercept injection	731.885	743.605	+1.6%
J0179	Inj, brolucizumab-dbll, 1 mg	353.069	359.713	+1.9%
J0180	Agalsidase beta injection	227.58	232.72	+2.3%
J0185	Inj., aprepitant, 1 mg	1.692	1.591	-6.0%
J0202	Injection, alemtuzumab	2,440.415	2,544.937	+4.3%
J0206	Inj allopurinol sodium 1 mg	3.809	4.074	+7.0%
J0217	Inj velmanase alfa-tycv 1 mg	465.234	479.191	+3.0%
J0218	Inj olipudase alfa-rpcp 1mg	395.598	404.947	+2.4%
J0219	Inj aval alfa-nqpt 4mg	81.204	83.945	+3.4%
J0221	Lumizyme injection	207.512	211.128	+1.7%
J0222	Inj., patisiran, 0.1 mg	100.896	101.026	+0.1%
J0223	Inj givosiran 0.5 mg	120.983	120.915	-0.1%
J0224	Inj. lumasiran, 0.5 mg	327.715	336.974	+2.8%
J0225	Inj, vutrisiran, 1 mg	5,019.273	5,012.599	-0.1%
J0248	Inj, remdesivir, 1 mg	6.898	7.511	+8.9%
J0256	Alpha 1 proteinase inhibitor	5.141	5.133	-0.2%
J0257	Glassia injection	5.66	5.583	-1.4%
J0278	Amikacin sulfate injection	0.61	0.614	+0.7%
J0280	Aminophyllin 250 mg inj	11.325	11.16	-1.5%
J0281	Inj aminocaproic acid 1 gram	1.567	1.866	+19.1%
J0283	Inj, amiodarone (nexterone)	2.488	2.358	-5.2%
J0285	Amphotericin b	44.331	41.918	-5.4%
J0289	Amphotericin b liposome inj	22.807	19.845	-13.0%
J0290	Ampicillin 500 mg inj	0.642	0.614	-4.4%
J0291	Inj., plazomicin, 5 mg	3.508	3.519	+0.3%
J0295	Ampicillin sulbactam 1.5 gm	1.352	1.451	+7.3%
J0349	Inj, rezafungin, 1 mg	10.787	10.998	+2.0%
J0360	Hydralazine hcl injection	4.288	3.395	-20.8%
J0401	Inj, abilify maintena, 1 mg	7.271	7.462	+2.6%
J0402	Inj, abilify asimtufii, 1 mg	6.022	6.185	+2.7%
J0456	Azithromycin	1.944	1.889	-2.8%
J0457	Injection, aztreonam, 100 mg	2.288	2.271	-0.7%
J0458	Aztreonam/avibactam 10 mg	1.675	1.773	+5.9%
J0475	Baclofen 10 mg injection	178.052	186.106	+4.5%
J0476	Baclofen intrathecal trial	54.338	43.84	-19.3%
J0480	Basiliximab	4,812.313	4,905.049	+1.9%
J0485	Belatacept injection	3.893	3.885	-0.2%
J0490	Belimumab injection	57.189	58.296	+1.9%
J0491	Inj anifrolumab-fnia 1mg	18.307	18.508	+1.1%
J0500	Dicyclomine injection	9.365	8.52	-9.0%
J0515	Inj benztropine mesylate	13.518	13.537	+0.1%
J0517	Inj., benralizumab, 1 mg	163.357	165.563	+1.4%
J0561	Penicillin g benzathine inj	31.465	32.592	+3.6%
J0577	Inj, brixadi, 7 days or less	417.21	430.576	+3.2%
J0578	Inj brixadi, more than 7 day	1,668.841	1,722.305	+3.2%
J0584	Injection, burosumab-twza 1m	498.716	513.371	+2.9%
J0585	Injection,onabotulinumtoxina	6.512	6.506	-0.1%
J0586	Abobotulinumtoxina	8.903	8.946	+0.5%
J0587	Inj, rimabotulinumtoxinb	13.283	13.287	0.0%
J0588	Incobotulinumtoxin a	5.289	5.285	-0.1%
J0589	Inj daxibotulinumtoxina-lanm	3.093	3.067	-0.8%
J0592	Buprenorphine hydrochloride	4.166	4.474	+7.4%
J0593	Inj., lanadelumab-flyo, 1 mg	86.846	88.216	+1.6%
J0594	Busulfan injection	0.677	1.033	+52.6%
J0595	Butorphanol tartrate 1 mg	6.146	10.508	+71.0%
J0596	Injection, ruconest	36.675	37.832	+3.2%
J0597	C-1 esterase, berinert	76.051	79.262	+4.2%
J0598	C-1 esterase, cinryze	65.501	66.753	+1.9%
J0600	Edetate calcium disodium inj	6,102.866	6,189.487	+1.4%
J0614	Inj, treosulfan, 50 mg	31.608	32.33	+2.3%
J0637	Caspofungin acetate	3.575	2.879	-19.5%
J0638	Canakinumab injection	149.574	156.541	+4.7%
J0640	Leucovorin calcium injection	3.591	2.932	-18.4%
J0642	Injection, khapzory, 0.5 mg	1.293	1.302	+0.7%
J0650	Inj, levothyroxine nos 10mcg	7.411	5.096	-31.2%
J0651	Inj, levothyroxine, freskabi	6.959	6.836	-1.8%
J0666	Inj, bupivacaine liposome	1.409	1.454	+3.2%
J0670	Inj mepivacaine hcl/10 ml	3.731	4.147	+11.1%
J0687	Inj cefazolin (wg crit care)	0.736	0.631	-14.3%
J0688	Inj cefazolin sodium, hikma	0.85	0.847	-0.4%
J0689	Inj cefazolin sodium, baxter	1.237	1.29	+4.3%
J0690	Cefazolin sodium injection	0.845	0.796	-5.8%
J0692	Cefepime hcl for injection	1.268	1.296	+2.2%
J0694	Cefoxitin sodium injection	3.559	4.285	+20.4%
J0695	Inj ceftolozane tazobactam	8.836	10.038	+13.6%
J0697	Sterile cefuroxime injection	1.992	2.044	+2.6%
J0699	Inj, cefiderocol, 10 mg	2.419	2.548	+5.3%
J0701	Inj. cefepime hcl (baxter)	5.908	6.027	+2.0%
J0702	Betamethasone acet&sod phosp	6.971	7.126	+2.2%
J0703	Inj, cefepime hcl (b braun)	4.888	4.479	-8.4%
J0712	Ceftaroline fosamil inj	4.254	4.39	+3.2%
J0713	Inj ceftazidime per 500 mg	1.405	1.443	+2.7%
J0714	Ceftazidime and avibactam	104.749	109.768	+4.8%
J0717	Certolizumab pegol inj 1mg	3.79	3.444	-9.1%
J0725	Chorionic gonadotropin/1000u	15.166	15.069	-0.6%
J0735	Clonidine hydrochloride	17.921	15.077	-15.9%
J0736	Inj, clindamycin phosp 300mg	1.855	1.974	+6.4%
J0737	Inj, clindamycin (baxter)	2.324	2.186	-5.9%
J0738	Hiv prep, inj, lenacapavir	16.103	16.081	-0.1%
J0739	Hiv prep, inj, cabotegravir	7.145	7.294	+2.1%
J0740	Cidofovir injection	560.789	535.735	-4.5%
J0741	Inj, cabote rilpivir 2mg 3mg	24.181	24.667	+2.0%
J0742	Inj imip 4 cilas 4 releb 2mg	2.596	2.691	+3.7%
J0743	Cilastatin sodium injection	6.324	6.517	+3.1%
J0744	Ciprofloxacin iv	0.755	1.72	+127.8%
J0751	Hiv prep, ftc/taf 200/25mg	71.435	71.427	0.0%
J0752	Hiv prep, oral lenacapavir	621.959	620.909	-0.2%
J0759	Inj, clevidipine, 1 mg	2.844	2.85	+0.2%
J0770	Colistimethate sodium inj	14.268	14.494	+1.6%
J0775	Collagenase, clost hist inj	78.352	78.299	-0.1%
J0780	Prochlorperazine injection	3.332	2.762	-17.1%
J0791	Inj crizanlizumab-tmca 5mg	129.944	129.937	0.0%
J0801	Inj. acthar gel to 40 units	4,094.259	4,133.449	+1.0%
J0802	Inj. (ani), up to 40 units	3,571.351	3,674.678	+2.9%
J0834	Inj., cosyntropin, 0.25 mg	16.258	18.384	+13.1%
J0840	Crotalidae poly immune fab	1,841.019	1,906.906	+3.6%
J0850	Cytomegalovirus imm iv /vial	1,808.607	1,858.821	+2.8%
J0870	Injection, imetelstat, 1 mg	58.169	59.531	+2.3%
J0875	Injection, dalbavancin	15.003	11.293	-24.7%
J0881	Darbepoetin alfa, non-esrd	3.072	2.92	-4.9%
J0882	Darbepoetin alfa, esrd use	3.072	2.92	-4.9%
J0883	Argatroban nonesrd use 1mg	1.013	0.864	-14.7%
J0884	Argatroban esrd dialysis 1mg	1.013	0.864	-14.7%
J0885	Epoetin alfa, non-esrd	7.305	6.876	-5.9%
J0887	Epoetin beta esrd use	1.033	1.09	+5.5%
J0888	Epoetin beta non esrd	1.033	1.09	+5.5%
J0894	Decitabine injection	1.001	1.064	+6.3%
J0895	Deferoxamine mesylate inj	8.577	10.02	+16.8%
J0896	Inj luspatercept-aamt 0.25mg	42.75	43.514	+1.8%
J0897	Denosumab injection	29.507	30.101	+2.0%
J0898	Argatroban nonesrd (auromed)	1.376	1.214	-11.8%
J0899	Argatroban dialysis, auromed	1.376	1.214	-11.8%
J1000	Depo-estradiol cypionate inj	51.82	53.811	+3.8%
J1096	Dexametha opth insert 0.1 mg	92.547	90.019	-2.7%
J1110	Inj dihydroergotamine mesylt	54.885	54.978	+0.2%
J1120	Acetazolamid sodium injectio	24.36	28.127	+15.5%
J1160	Digoxin injection	10.372	3.911	-62.3%
J1162	Digoxin immune fab (ovine)	5,166.991	5,383.321	+4.2%
J1190	Dexrazoxane hcl injection	49.738	41.441	-16.7%
J1200	Diphenhydramine hcl injectio	0.687	0.752	+9.5%
J1201	Inj. cetirizine hcl 0.5mg	16.922	17.156	+1.4%
J1203	Inj, cipaglucosidase, 5 mg	92.398	96.302	+4.2%
J1205	Chlorothiazide sodium inj	46.921	77.771	+65.7%
J1212	Dimethyl sulfoxide 50% 50 ml	748.975	748.879	0.0%
J1230	Methadone injection	14.706	12.707	-13.6%
J1240	Dimenhydrinate injection	7.717	8.638	+11.9%
J1250	Inj dobutamine hcl/250 mg	7.882	7.691	-2.4%
J1265	Dopamine injection	0.801	1.012	+26.3%
J1290	Ecallantide injection	578.747	595.944	+3.0%
J1299	Inj, eculizumab, 2 mg	44.699	44.344	-0.8%
J1301	Injection, edaravone, 1 mg	15.178	6.463	-57.4%
J1303	Inj., ravulizumab-cwvz 10 mg	223.675	227.629	+1.8%
J1304	Inj tofersen intrathec 1 mg	160.01	164.816	+3.0%
J1306	Injection, inclisiran, 1 mg	12.61	12.905	+2.3%
J1322	Elosulfase alfa, injection	311.946	319.517	+2.4%
J1323	Inj, elranatamab-bcmm, 1 mg	186.791	192.482	+3.0%
J1325	Epoprostenol injection	14.876	16.918	+13.7%
J1326	Inj, zolbetuximab-clzb, 2 mg	33.649	33.924	+0.8%
J1335	Ertapenem injection	7.217	6.75	-6.5%
J1364	Erythro lactobionate /500 mg	91.226	172.479	+89.1%
J1380	Estradiol valerate 10 mg inj	7.189	7.702	+7.1%
J1410	Inj estrogen conjugate 25 mg	391.718	401.503	+2.5%
J1430	Ethanolamine oleate 100 mg	518.627	547.271	+5.5%
J1434	Inj, focinvez, 1mg	2.547	2.456	-3.6%
J1437	Inj. fe derisomaltose 10 mg	21.93	21.077	-3.9%
J1439	Inj ferric carboxymaltos 1mg	1.103	1.132	+2.6%
J1440	Fecal microbiota jslm 1 ml	64.322	65.604	+2.0%
J1442	Inj filgrastim excl biosimil	1.016	1.006	-1.0%
J1448	Injection, trilaciclib, 1mg	5.488	5.463	-0.5%
J1449	Inj eflapegrastim-xnst 0.1mg	38.955	38.562	-1.0%
J1450	Fluconazole	3.874	6.105	+57.6%
J1454	Inj fosnetupitant, palonoset	524.177	503.848	-3.9%
J1455	Foscarnet sodium injection	8.356	8.355	0.0%
J1458	Galsulfase injection	513.595	525.967	+2.4%
J1459	Inj ivig privigen 500 mg	49.533	51.218	+3.4%
J1460	Gamma globulin 1 cc inj	48.953	48.874	-0.2%
J1551	Inj cutaquig 100 mg	13.927	14.03	+0.7%
J1552	Inj, alyglo, 500 mg	123.125	121.544	-1.3%
J1553	Inj yimmugo 100 mg	24.323	24.145	-0.7%
J1554	Inj. asceniv	500.926	509.139	+1.6%
J1555	Inj cuvitru, 100 mg	17.58	18.147	+3.2%
J1556	Inj, imm glob bivigam, 500mg	79.441	81.241	+2.3%
J1557	Gammaplex injection	64.65	66.272	+2.5%
J1558	Inj. xembify, 100 mg	15.367	15.243	-0.8%
J1559	Hizentra injection	14.515	14.883	+2.5%
J1560	Gamma globulin > 10 cc inj	160.286	162.519	+1.4%
J1561	Gamunex-c/gammaked	49.726	49.014	-1.4%
J1566	Immune globulin, powder	80.395	80.961	+0.7%
J1568	Octagam injection	47.035	47.056	0.0%
J1569	Gammagard liquid injection	49.081	49.303	+0.5%
J1570	Ganciclovir sodium injection	34.047	31.464	-7.6%
J1571	Hepagam b im injection	70.234	65.61	-6.6%
J1573	Hepagam b intravenous, inj	70.234	65.61	-6.6%
J1575	Hyqvia 100mg immuneglobulin	18.804	18.347	-2.4%
J1576	Inj, panzyga, 500 mg	73.83	71.346	-3.4%
J1580	Garamycin gentamicin inj	1.928	1.925	-0.2%
J1597	Inj glycopyrrolate, glyrx-pf	1.351	1.317	-2.5%
J1602	Golimumab for iv use 1mg	11.287	11.035	-2.2%
J1610	Glucagon hydrochloride/1 mg	146.332	117.331	-19.8%
J1611	Inj glucagon hcl, fresenius	135.00	129.281	-4.2%
J1612	Inj glucagon (gvoke) 0.01 mg	2.365	1.799	-23.9%
J1627	Inj, granisetron, xr, 0.1 mg	3.876	3.217	-17.0%
J1628	Inj., guselkumab, 1 mg	67.813	66.92	-1.3%
J1630	Haloperidol injection	0.789	0.746	-5.4%
J1631	Haloperidol decanoate inj	6.07	5.291	-12.8%
J1640	Hemin, 1 mg	35.309	35.821	+1.5%
J1643	Inj heparin, pfizer, 1000u	1.146	1.711	+49.3%
J1645	Dalteparin sodium	15.863	48.413	+205.2%
J1650	Inj enoxaparin sodium	0.542	0.536	-1.1%
J1652	Fondaparinux sodium	0.797	0.925	+16.1%
J1670	Tetanus immune globulin inj	558.118	595.017	+6.6%
J1720	Hydrocortisone sodium succ i	22.141	23.056	+4.1%
J1740	Ibandronate sodium injection	9.057	45.154	+398.6%
J1741	Ibuprofen injection	3.177	3.252	+2.4%
J1743	Idursulfase injection	558.221	570.043	+2.1%
J1745	Infliximab not biosimil 10mg	31.041	31.479	+1.4%
J1746	Inj., ibalizumab-uiyk, 10 mg	77.675	79.512	+2.4%
J1749	Inj, iloprost, 0.1 mcg	5.709	5.651	-1.0%
J1750	Inj iron dextran	18.105	18.993	+4.9%
J1786	Imuglucerase injection	42.825	43.326	+1.2%
J1790	Droperidol injection	7.214	8.124	+12.6%
J1809	Inj, fosdenopterin, 0.1mg	17.588	17.736	+0.8%
J1811	Fiasp for insulin pump use	8.763	1.727	-80.3%
J1813	Lyumjev for insulin pump use	15.104	4.802	-68.2%
J1817	Insulin for insulin pump use	3.128	3.062	-2.1%
J1823	Inj. inebilizumab-cdon, 1 mg	495.545	510.652	+3.0%
J1921	Inj labetalol hcl hikma, 5mg	0.903	0.906	+0.3%
J1930	Lanreotide injection	35.722	37.428	+4.8%
J1931	Laronidase injection	39.954	41.487	+3.8%
J1932	Inj, lanreotide, (cipla) 1mg	32.19	20.33	-36.8%
J1943	Inj., aristada initio, 1 mg	3.251	3.461	+6.5%
J1944	Aripiprazole lauroxil 1 mg	3.316	3.557	+7.3%
J1950	Leuprolide acetate /3.75 mg	1,765.574	1,841.261	+4.3%
J1951	Inj fensolvi 0.25 mg	140.709	145.311	+3.3%
J1952	Leuprolide inj, camcevi, 1mg	39.947	42.059	+5.3%
J1954	Inj leu acet lutr dpt 7.5 mg	693.557	687.287	-0.9%
J1955	Inj levocarnitine per 1 gm	23.087	22.607	-2.1%
J1956	Levofloxacin injection	2.163	1.909	-11.7%
J1961	Inj lenacapavir (hiv tx) 1mg	22.298	22.936	+2.9%
J2010	Lincomycin injection	4.715	4.234	-10.2%
J2020	Linezolid injection	2.483	2.268	-8.7%
J2021	Inj, linezolid (hospira)	26.834	34.175	+27.4%
J2060	Lorazepam injection	1.66	2.302	+38.7%
J2175	Meperidine hydrochl /100 mg	8.817	6.339	-28.1%
J2182	Injection, mepolizumab, 1mg	31.823	32.281	+1.4%
J2183	Inj meropenem (wg crit care)	1.476	1.408	-4.6%
J2184	Inj, meropenem (b. braun)	1.974	1.867	-5.4%
J2210	Methylergonovin maleate inj	21.612	21.552	-0.3%
J2260	Inj milrinone lactate / 5 mg	1.183	1.098	-7.2%
J2267	Inj, mirikizumab-mrkz, 1 mg	42.092	32.658	-22.4%
J2270	Morphine sulfate injection	4.449	8.087	+81.8%
J2272	Inj, morphine (fresenius)	8.341	8.455	+1.4%
J2274	Inj morphine pf epid ithc	12.149	18.914	+55.7%
J2278	Ziconotide injection	10.464	10.793	+3.1%
J2300	Inj nalbuphine hydrochloride	3.421	4.287	+25.3%
J2305	Inj, nitroglycerin, 5 mg	1.665	1.557	-6.5%
J2315	Naltrexone, depot form	4.246	4.525	+6.6%
J2323	Natalizumab injection	24.321	24.406	+0.3%
J2327	Inj risankizumab-rzaa 1 mg	14.599	14.531	-0.5%
J2329	Inj ublituximab-xiiy, 1 mg	68.747	72.239	+5.1%
J2350	Injection, ocrelizumab, 1 mg	59.596	60.97	+2.3%
J2351	Inj ocrelizumab 1mg hya-ocsq	46.794	48.06	+2.7%
J2353	Octreotide injection, depot	188.35	208.095	+10.5%
J2354	Octreotide inj, non-depot	0.624	0.596	-4.5%
J2356	Inj tezepelumab-ekko, 1mg	17.583	17.92	+1.9%
J2357	Omalizumab injection	41.823	46.588	+11.4%
J2358	Olanzapine long-acting inj	3.186	3.199	+0.4%
J2359	Inj. olanzapine, 0.5mg	0.711	0.693	-2.5%
J2360	Orphenadrine injection	8.218	7.777	-5.4%
J2403	Chloroprocaine opht gel, 1mg	0.591	0.721	+22.0%
J2406	Injection, oritavancin 10 mg	43.719	47.409	+8.4%
J2407	Injection, oritavancin	28.567	29.727	+4.1%
J2425	Palifermin injection	36.719	38.69	+5.4%
J2426	Inj, invega sustenna, 1 mg	15.077	15.431	+2.3%
J2427	Inj, invega hafyera/trinza	12.949	13.262	+2.4%
J2428	Inj, erzofri, 1 mg	14.491	15.873	+9.5%
J2430	Pamidronate disodium /30 mg	12.424	12.025	-3.2%
J2468	Inj, palonosetron (posfrea)	55.289	55.23	-0.1%
J2469	Palonosetron hcl	0.649	0.574	-11.6%
J2501	Paricalcitol	1.022	0.899	-12.0%
J2502	Inj, pasireotide long acting	596.301	616.708	+3.4%
J2506	Inj pegfilgrast ex bio 0.5mg	127.379	143.233	+12.4%
J2507	Pegloticase injection	3,824.523	3,929.337	+2.7%
J2508	Pegunigalsidase alfa-iwxj	223.40	225.933	+1.1%
J2540	Penicillin g potassium inj	0.683	0.637	-6.7%
J2543	Piperacillin/tazobactam	1.085	1.218	+12.3%
J2545	Pentamidine non-comp unit	73.565	72.997	-0.8%
J2550	Promethazine hcl injection	3.344	3.639	+8.8%
J2560	Phenobarbital sodium inj	23.647	24.769	+4.7%
J2562	Plerixafor injection	32.743	28.489	-13.0%
J2596	Vasopressin (long grove) 1 u	1.184	1.134	-4.2%
J2597	Inj desmopressin acetate	3.413	3.562	+4.4%
J2598	Inj, vasopressin, 1 unit	0.532	0.49	-7.9%
J2599	Inj vasopressin (am reg) 1 u	0.836	0.834	-0.2%
J2601	Inj, vasopressin (baxter)	1.532	1.753	+14.4%
J2675	Inj progesterone per 50 mg	0.655	0.559	-14.7%
J2679	Inj fluphenazine hcl 1.25 mg	7.345	7.268	-1.0%
J2680	Fluphenazine decanoate 25 mg	5.586	5.781	+3.5%
J2690	Procainamide hcl injection	214.811	295.361	+37.5%
J2700	Oxacillin sodium injeciton	0.854	0.763	-10.7%
J2720	Inj protamine sulfate/10 mg	1.669	1.768	+5.9%
J2724	Protein c concentrate	15.049	15.071	+0.1%
J2760	Phentolaine mesylate inj	257.449	288.625	+12.1%
J2765	Metoclopramide hcl injection	0.953	1.004	+5.4%
J2777	Inj, faricimab-svoa, 0.1mg	32.866	32.381	-1.5%
J2778	Ranibizumab injection	67.853	51.09	-24.7%
J2779	Inj, susvimo 0.1 mg	76.199	74.795	-1.8%
J2781	Inj, pegcetacoplan, 1mg	147.807	148.944	+0.8%
J2782	Inj avacincaptad pegol 0.1mg	103.401	103.203	-0.2%
J2783	Rasburicase	382.187	387.453	+1.4%
J2785	Regadenoson injection	2.902	2.79	-3.9%
J2786	Injection, reslizumab, 1mg	11.532	11.729	+1.7%
J2788	Rho d immune globulin 50 mcg	27.521	25.542	-7.2%
J2790	Rho d immune globulin inj	78.899	85.125	+7.9%
J2791	Rhophylac injection	4.846	4.878	+0.7%
J2792	Rho(d) immune globulin h, sd	34.255	35.791	+4.5%
J2794	Inj risperdal consta, 0.5 mg	10.796	11.105	+2.9%
J2798	Inj., perseris, 0.5 mg	12.173	12.204	+0.3%
J2799	Inj, uzedy, 1 mg	25.156	26.181	+4.1%
J2800	Methocarbamol injection	4.202	4.509	+7.3%
J2802	Inj, romiplostim 1 microgram	11.107	11.617	+4.6%
J2805	Sincalide injection	108.203	110.462	+2.1%
J2820	Sargramostim injection	61.888	62.474	+0.9%
J2860	Injection, siltuximab	174.075	174.066	0.0%
J2916	Na ferric gluconate complex	2.393	2.197	-8.2%
J2997	Alteplase recombinant	95.09	98.587	+3.7%
J3000	Streptomycin injection	40.256	26.883	-33.2%
J3010	Fentanyl citrate injection	1.163	1.385	+19.1%
J3032	Inj. eptinezumab-jjmr 1 mg	20.546	21.101	+2.7%
J3055	Inj talquetamab-tgvs 0.25 mg	74.876	76.721	+2.5%
J3060	Inj, taliglucerase alfa 10 u	40.657	42.675	+5.0%
J3090	Inj tedizolid phosphate	1.964	2.081	+6.0%
J3095	Telavancin injection	7.032	7.484	+6.4%
J3101	Tenecteplase injection	197.441	217.421	+10.1%
J3105	Terbutaline sulfate inj	2.963	2.82	-4.8%
J3111	Inj. romosozumab-aqqg 1 mg	12.187	12.732	+4.5%
J3145	Testosterone undecanoate 1mg	2.131	2.149	+0.8%
J3230	Chlorpromazine hcl injection	20.958	18.143	-13.4%
J3240	Thyrotropin injection	2,125.337	2,158.661	+1.6%
J3241	Inj. teprotumumab-trbw 10 mg	367.908	379.90	+3.3%
J3243	Tigecycline injection	0.569	0.517	-9.1%
J3245	Inj., tildrakizumab, 1 mg	118.199	124.273	+5.1%
J3246	Tirofiban hcl	3.194	2.917	-8.7%
J3247	Inj secukinumab intrav 1mg	18.042	18.233	+1.1%
J3250	Trimethobenzamide hcl inj	57.22	62.935	+10.0%
J3260	Tobramycin sulfate injection	2.019	2.186	+8.3%
J3262	Tocilizumab injection	5.53	5.408	-2.2%
J3263	Inj, toripalimab-tpzi, 1 mg	39.993	40.893	+2.3%
J3285	Treprostinil injection	55.185	54.74	-0.8%
J3299	Inj xipere 1 mg	47.779	47.77	0.0%
J3300	Triamcinolone a inj prs-free	18.78	19.186	+2.2%
J3301	Triamcinolone acet inj nos	0.895	0.996	+11.3%
J3304	Inj triamcinolone ace xr 1mg	18.636	19.28	+3.5%
J3315	Triptorelin pamoate	469.376	466.365	-0.6%
J3316	Inj., triptorelin xr 3.75 mg	3,723.756	3,819.934	+2.6%
J3358	Ustekinumab, iv inject, 1 mg	11.624	11.356	-2.3%
J3360	Diazepam injection	8.508	6.854	-19.4%
J3380	Inj vedolizumab iv 1 mg	20.98	21.622	+3.1%
J3385	Velaglucerase alfa	388.157	392.843	+1.2%
J3396	Verteporfin injection	11.574	11.374	-1.7%
J3401	Vyjuvek 5x10^9pfu/ml, 0.1 ml	1,004.582	1,032.437	+2.8%
J3402	Inj. remestemcel-l-rknd/ td	202,713.584	203,659.763	+0.5%
J3410	Hydroxyzine hcl injection	15.165	15.209	+0.3%
J3411	Thiamine hcl 100 mg	1.554	1.596	+2.7%
J3415	Pyridoxine hcl 100 mg	14.895	12.941	-13.1%
J3420	Vitamin b12 injection	0.667	0.683	+2.4%
J3430	Vitamin k phytonadione inj	3.156	3.253	+3.1%
J3465	Injection, voriconazole	0.652	0.563	-13.7%
J3470	Hyaluronidase injection	31.55	31.764	+0.7%
J3486	Ziprasidone mesylate	5.873	5.602	-4.6%
J3489	Zoledronic acid 1mg	30.878	3.361	-89.1%
J7030	Normal saline solution infus	2.185	2.181	-0.2%
J7040	Normal saline solution infus	1.355	1.35	-0.4%
J7042	5% dextrose/normal saline	1.285	1.215	-5.4%
J7060	5% dextrose/water	1.874	1.649	-12.0%
J7070	D5w infusion	3.07	2.847	-7.3%
J7120	Ringers lactate infusion	2.601	2.313	-11.1%
J7170	Inj., emicizumab-kxwh 0.5 mg	55.64	58.032	+4.3%
J7171	Inj, adzynma, 10 iu	35.576	36.214	+1.8%
J7172	Inj marstacim-hncq, 0.5 mg	50.191	51.191	+2.0%
J7173	Inj. concizumab-mtci, 0.5 mg	83.472	86.158	+3.2%
J7174	Injection fitusiran 0.04 mg	132.626	131.202	-1.1%
J7177	Inj., fibryga, 1 mg	1.237	1.233	-0.3%
J7178	Inj human fibrinogen con nos	1.524	1.488	-2.4%
J7179	Vonvendi inj 1 iu vwf:rco	1.83	1.811	-1.0%
J7180	Factor xiii anti-hem factor	10.778	11.235	+4.2%
J7181	Factor xiii recomb a-subunit	18.331	19.114	+4.3%
J7182	Factor viii recomb novoeight	1.41	1.443	+2.3%
J7183	Wilate injection	1.32	1.326	+0.5%
J7185	Xyntha inj	1.491	1.371	-8.0%
J7186	Antihemophilic viii/vwf comp	1.252	1.269	+1.4%
J7187	Humate-p, inj	1.494	1.535	+2.7%
J7189	Factor viia recomb novoseven	2.64	2.772	+5.0%
J7190	Factor viii	1.393	1.246	-10.6%
J7192	Factor viii recombinant nos	1.568	1.58	+0.8%
J7193	Factor ix non-recombinant	1.369	1.403	+2.5%
J7194	Factor ix complex	1.704	1.747	+2.5%
J7195	Factor ix recombinant nos	1.836	1.864	+1.5%
J7197	Antithrombin iii injection	4.10	4.174	+1.8%
J7198	Anti-inhibitor	2.418	2.447	+1.2%
J7200	Factor ix recombinan rixubis	1.742	1.717	-1.4%
J7201	Factor ix alprolix recomb	3.58	3.711	+3.7%
J7202	Factor ix idelvion inj	5.319	5.507	+3.5%
J7203	Factor ix recomb gly rebinyn	4.496	4.674	+4.0%
J7204	Inj recombin esperoct per iu	2.225	2.296	+3.2%
J7205	Factor viii fc fusion recomb	2.462	2.578	+4.7%
J7207	Factor viii pegylated recomb	2.142	2.119	-1.1%
J7208	Inj. jivi 1 iu	2.655	2.756	+3.8%
J7209	Factor viii nuwiq recomb 1iu	1.182	1.221	+3.3%
J7210	Inj, afstyla, 1 i.u.	1.572	1.619	+3.0%
J7211	Inj, kovaltry, 1 i.u.	1.564	1.595	+2.0%
J7212	Factor viia recomb sevenfact	2.198	2.194	-0.2%
J7213	Inj, ixinity, 1 i.u.	1.973	1.939	-1.7%
J7214	Altuviiio per factor viii iu	4.492	4.632	+3.1%
J7308	Aminolevulinic acid hcl top	390.016	389.28	-0.2%
J7311	Inj., retisert, 0.01 mg	338.792	338.804	0.0%
J7312	Dexamethasone intra implant	203.793	203.656	-0.1%
J7313	Inj., iluvien, 0.01 mg	509.81	516.406	+1.3%
J7318	Inj, durolane 1 mg	6.732	6.239	-7.3%
J7320	Genvisc 850, inj, 1mg	3.676	3.808	+3.6%
J7321	Hyalgan supartz visco-3 dose	74.434	70.282	-5.6%
J7322	Hymovis injection 1 mg	18.134	18.131	0.0%
J7323	Euflexxa inj per dose	105.58	98.137	-7.0%
J7324	Orthovisc inj per dose	109.094	100.331	-8.0%
J7325	Synvisc or synvisc-one	6.963	6.018	-13.6%
J7326	Gel-one	526.786	533.592	+1.3%
J7327	Monovisc inj per dose	655.337	565.275	-13.7%
J7328	Gelsyn-3 injection 0.1 mg	0.68	0.584	-14.1%
J7329	Inj, trivisc 1 mg	3.273	3.036	-7.2%
J7332	Inj., triluron, 1 mg	10.545	10.43	-1.1%
J7336	Capsaicin 8% patch	3.423	3.509	+2.5%
J7340	Carbidopa levodopa ent 100ml	244.041	244.497	+0.2%
J7345	Aminolevulinic acid, 10% gel	1.774	1.848	+4.2%
J7351	Inj bimatoprost itc imp1mcg	214.02	213.756	-0.1%
J7354	Cantharidin top, applicator	667.073	695.208	+4.2%
J7355	Inj travoprost intra impl	196.878	196.746	-0.1%
J7502	Cyclosporine oral 100 mg	1.428	1.559	+9.2%
J7503	Tacrol envarsus ex rel oral	1.862	1.863	+0.1%
J7504	Lymphocyte immune globulin	5,292.432	5,548.962	+4.8%
J7508	Tacrol astagraf ex rel oral	0.586	0.601	+2.6%
J7510	Prednisolone oral per 5 mg	0.74	0.777	+5.0%
J7511	Antithymocyte globuln rabbit	1,023.124	1,057.791	+3.4%
J7514	Mycophenol (myhibbin) 100 mg	2.25	2.296	+2.0%
J7515	Cyclosporine oral 25 mg	0.626	0.552	-11.8%
J7516	Inj, cyclosporine 250mg	74.202	75.649	+2.0%
J7520	Sirolimus, oral	1.266	0.744	-41.2%
J7521	Tacrolim granules oral susp	1.282	1.303	+1.6%
J7525	Tacrolimus injection	259.956	268.176	+3.2%
J7527	Oral everolimus	1.244	1.163	-6.5%
J7605	Arformoterol non-comp unit	0.727	0.742	+2.1%
J7606	Formoterol fumarate, inh	1.783	1.547	-13.2%
J7608	Acetylcysteine non-comp unit	8.541	7.274	-14.8%
J7626	Budesonide non-comp unit	1.095	1.092	-0.3%
J7631	Cromolyn sodium noncomp unit	0.814	0.691	-15.1%
J7639	Dornase alfa non-comp unit	55.172	56.78	+2.9%
J7682	Tobramycin non-comp unit	7.766	12.305	+58.4%
J7686	Treprostinil, non-comp unit	789.177	832.827	+5.5%
J8501	Oral aprepitant	2.389	3.069	+28.5%
J8502	Inj, aponvie, 1 mg	1.953	1.998	+2.3%
J8530	Cyclophosphamide oral 25 mg	1.649	1.491	-9.6%
J8560	Etoposide oral 50 mg	86.84	88.055	+1.4%
J8611	Oral methotrexate (jylamvo)	18.71	16.467	-12.0%
J8612	Oral methotrexate (xatmep)	22.296	22.915	+2.8%
J8655	Oral netupitant, palonosetro	397.793	474.038	+19.2%
J8705	Topotecan oral	125.224	125.334	+0.1%
J9000	Doxorubicin hcl injection	2.729	2.71	-0.7%
J9011	Datopotamab deruxtecan, 1 mg	51.516	52.499	+1.9%
J9017	Arsenic trioxide injection	6.445	5.069	-21.3%
J9021	Inj, aspara, rylaze, 0.1 mg	56.286	58.698	+4.3%
J9022	Inj, atezolizumab,10 mg	93.997	96.546	+2.7%
J9023	Injection, avelumab, 10 mg	105.545	108.636	+2.9%
J9024	Inj atezolizumb 5mg hya-tqjs	31.947	32.554	+1.9%
J9026	Inj, tarlatamab-dlle, 1 mg	1,567.718	1,612.421	+2.9%
J9027	Clofarabine injection	10.937	16.245	+48.5%
J9028	Inj, nogapendekin pmln, 1mcg	94.598	94.306	-0.3%
J9029	Instill adstiladrin, tx dose	64,282.299	64,331.614	+0.1%
J9030	Bcg live intravesical 1mg	3.391	3.376	-0.4%
J9032	Injection, belinostat, 10mg	53.111	54.446	+2.5%
J9033	Inj, bendamustine hcl, 1mg	2.159	2.96	+37.1%
J9034	Inj., bendeka 1 mg	12.901	12.532	-2.9%
J9035	Bevacizumab injection	74.355	74.823	+0.6%
J9036	Inj. belrapzo/bendamustine	13.942	11.599	-16.8%
J9038	Inj axatilimab-csfr 0.1 mg	55.65	56.461	+1.5%
J9039	Injection, blinatumomab	163.96	172.90	+5.5%
J9040	Bleomycin sulfate injection	16.598	24.838	+49.6%
J9041	Injection, bortezomib, 0.1mg	2.253	2.037	-9.6%
J9042	Brentuximab vedotin inj	268.727	279.207	+3.9%
J9043	Cabazitaxel injection	231.048	233.73	+1.2%
J9045	Carboplatin injection	2.937	3.153	+7.4%
J9047	Injection, carfilzomib, 1 mg	56.239	60.291	+7.2%
J9049	Inj, bortezomib, hospira	1.259	1.712	+36.0%
J9050	Carmustine injection	241.803	240.011	-0.7%
J9054	Inj bortezomib boruzu 0.1 mg	25.41	24.747	-2.6%
J9055	Cetuximab injection	80.457	81.666	+1.5%
J9056	Inj, vivimusta, 1 mg	31.736	29.913	-5.7%
J9060	Cisplatin 10 mg injection	2.166	2.13	-1.7%
J9061	Inj, amivantamab-vmjw	22.631	23.219	+2.6%
J9063	Inj, elahere, 1 mg	71.128	71.991	+1.2%
J9065	Inj cladribine per 1 mg	8.726	8.188	-6.2%
J9071	Inj cyclophosphamd auromedic	0.519	0.49	-5.6%
J9072	Inj cyclophos frindovyx 5 mg	9.103	8.922	-2.0%
J9073	Inj cyclophos dr reddys 5 mg	0.503	0.498	-1.0%
J9074	Inj, cyclophosphamd, sandoz	3.653	3.438	-5.9%
J9075	Inj, cyclophosphamide, nos	0.773	0.575	-25.6%
J9076	Inj, cyclophos (baxter) 5mg	3.724	4.387	+17.8%
J9100	Cytarabine hcl 100 mg inj	0.799	0.853	+6.8%
J9118	Inj. calaspargase pegol-mknl	82.075	85.789	+4.5%
J9119	Inj., cemiplimab-rwlc, 1 mg	29.762	29.668	-0.3%
J9120	Dactinomycin injection	337.669	307.411	-9.0%
J9130	Dacarbazine 100 mg inj	3.852	3.463	-10.1%
J9144	Daratumumab, hyaluronidase	55.032	57.051	+3.7%
J9145	Injection, daratumumab 10 mg	70.774	73.77	+4.2%
J9150	Daunorubicin injection	24.748	28.81	+16.4%
J9153	Inj daunorubicin, cytarabine	261.195	272.886	+4.5%
J9155	Degarelix injection	4.458	4.481	+0.5%
J9171	Docetaxel injection	0.556	0.456	-18.0%
J9172	Docetaxel (docivyx), 1 mg	50.607	46.287	-8.5%
J9173	Inj., durvalumab, 10 mg	86.146	87.95	+2.1%
J9176	Injection, elotuzumab, 1mg	8.041	8.189	+1.8%
J9177	Inj enfort vedo-ejfv 0.25mg	36.707	36.658	-0.1%
J9178	Inj, epirubicin hcl, 2 mg	1.767	1.994	+12.8%
J9179	Eribulin mesylate injection	76.756	59.979	-21.9%
J9181	Etoposide injection	0.90	1.018	+13.1%
J9183	Gemcitabine intravesical sys	73,088.26	72,984.241	-0.1%
J9184	Inj gemcitabin (avyxa) 200mg	410.439	400.334	-2.5%
J9185	Fludarabine phosphate inj	217.726	206.299	-5.2%
J9190	Fluorouracil injection	2.056	2.024	-1.6%
J9200	Floxuridine injection	4,250.967	4,396.492	+3.4%
J9201	In gemcitabine hcl nos 200mg	3.237	2.884	-10.9%
J9203	Gemtuzumab ozogamicin 0.1 mg	240.165	247.37	+3.0%
J9204	Inj mogamulizumab-kpkc, 1 mg	253.467	258.536	+2.0%
J9205	Inj irinotecan liposome 1 mg	66.374	65.861	-0.8%
J9206	Irinotecan injection	1.532	1.851	+20.8%
J9207	Ixabepilone injection	139.749	139.754	0.0%
J9208	Ifosfamide injection	24.682	27.613	+11.9%
J9209	Mesna injection	1.334	1.305	-2.2%
J9210	Inj., emapalumab-lzsg, 1 mg	384.135	392.78	+2.3%
J9211	Idarubicin hcl injection	39.756	38.132	-4.1%
J9217	Leuprolide acetate suspnsion	176.20	160.342	-9.0%
J9223	Inj. lurbinectedin, 0.1 mg	212.099	215.95	+1.8%
J9226	Supprelin la implant	41,173.427	37,491.974	-8.9%
J9227	Inj. isatuximab-irfc 10 mg	83.577	88.16	+5.5%
J9228	Ipilimumab injection	187.166	190.432	+1.7%
J9229	Inj inotuzumab ozogam 0.1 mg	2,816.767	2,873.103	+2.0%
J9245	Inj melpha hydroch nos 50 mg	120.668	104.898	-13.1%
J9246	Inj., evomela, 1 mg	19.429	18.044	-7.1%
J9248	Inj melphalan (hepzato) 1 mg	795.00	801.479	+0.8%
J9256	Inj, nipocalimab-aahu, 3 mg	32.67	32.568	-0.3%
J9260	Inj methotrexate sodium 50mg	2.677	2.941	+9.9%
J9261	Nelarabine injection	52.707	65.407	+24.1%
J9264	Paclitaxel protein bound	6.02	6.586	+9.4%
J9266	Pegaspargase injection	28,424.059	29,663.965	+4.4%
J9268	Pentostatin injection	2,626.328	2,697.987	+2.7%
J9269	Inj. tagraxofusp-erzs 10 mcg	357.279	357.522	+0.1%
J9271	Inj pembrolizumab	61.251	60.645	-1.0%
J9272	Inj, dostarlimab-gxly, 10 mg	247.083	251.298	+1.7%
J9274	Inj, tebentafusp-tebn, 1 mcg	222.494	228.006	+2.5%
J9276	Inj zanidatamab-hrii, 2 mg	24.996	25.663	+2.7%
J9277	Pembrolizumab 1mg berahyalur	32.129	31.94	-0.6%
J9278	Inj, carboplatin (avyxa)	5.242	5.203	-0.7%
J9280	Mitomycin injection	28.459	34.107	+19.8%
J9281	Mitomycin instillation	323.171	329.937	+2.1%
J9282	Mitomycin intravesical inst	278.332	274.342	-1.4%
J9286	Inj glofitamab gxbm, 2.5 mg	2,840.677	2,864.678	+0.8%
J9289	Inj nivolumab 2 mg hyaluron	27.729	28.14	+1.5%
J9292	Inj, pemetrexed dipotassium	82.019	73.67	-10.2%
J9293	Mitoxantrone hydrochl / 5 mg	38.614	29.702	-23.1%
J9294	Inj pemetrexed, hospira 10mg	5.198	2.943	-43.4%
J9297	Inj pemetrexed (sandoz) 10mg	1.459	4.879	+234.4%
J9298	Inj nivol relatlimab 3mg/1mg	201.755	205.511	+1.9%
J9299	Injection, nivolumab	33.624	34.222	+1.8%
J9301	Obinutuzumab inj	81.806	84.463	+3.2%
J9303	Panitumumab injection	174.386	182.189	+4.5%
J9305	Inj. pemetrexed nos 10mg	4.038	6.952	+72.2%
J9306	Injection, pertuzumab, 1 mg	17.016	17.20	+1.1%
J9307	Pralatrexate injection	392.719	386.122	-1.7%
J9308	Injection, ramucirumab	75.472	76.565	+1.4%
J9309	Inj, polatuzumab vedotin 1mg	137.227	143.611	+4.7%
J9311	Inj rituximab, hyaluronidase	36.282	36.389	+0.3%
J9312	Inj., rituximab, 10 mg	74.158	73.278	-1.2%
J9316	Pertuzu, trastuzu, 10 mg	60.225	59.895	-0.5%
J9317	Sacituzumab govitecan-hziy	36.797	37.64	+2.3%
J9319	Inj romidepsin lyophil 0.1mg	30.796	30.713	-0.3%
J9321	Inj epcoritamab-bysp 0.16 mg	56.916	57.992	+1.9%
J9324	Inj, pemrydi rtu, 10 mg	70.476	67.935	-3.6%
J9325	Inj talimogene laherparepvec	73.942	77.339	+4.6%
J9326	Telisotuzumab vedotin-tllv	145.994	146.06	0.0%
J9328	Temozolomide injection	10.399	10.408	+0.1%
J9329	Inj, tislelizumab-jsgr	58.27	58.169	-0.2%
J9330	Temsirolimus injection	30.078	32.681	+8.7%
J9331	Inj sirolimus prot part 1 mg	87.11	91.03	+4.5%
J9332	Inj efgartigimod 2mg	32.608	32.553	-0.2%
J9333	Inj rozanolixizum-noli 1 mg	23.396	23.588	+0.8%
J9334	Inj efgart-alfa 2mg hya-qvfc	34.325	34.258	-0.2%
J9341	Inj thiotepa (tepylute) 1 mg	38.55	36.64	-5.0%
J9342	Inj thiotepa nos 1 mg	5.738	4.931	-14.1%
J9345	Inj, retifanlimab-dlwr, 1 mg	30.403	30.981	+1.9%
J9347	Inj, tremelimumab-actl, 1 mg	143.228	146.894	+2.6%
J9348	Inj. naxitamab-gqgk, 1 mg	686.092	684.898	-0.2%
J9349	Inj., tafasitamab-cxix	14.166	14.429	+1.9%
J9350	Inj mosunetuzumab-axgb, 1 mg	654.542	674.495	+3.0%
J9351	Topotecan injection	2.111	2.759	+30.7%
J9352	Injection trabectedin 0.1mg	391.07	410.479	+5.0%
J9353	Inj. margetuximab-cmkb, 5 mg	53.272	56.442	+6.0%
J9354	Inj, ado-trastuzumab emt 1mg	42.198	43.626	+3.4%
J9355	Inj trastuzumab excl biosimi	73.425	70.243	-4.3%
J9356	Inj. herceptin hylecta, 10mg	59.909	58.344	-2.6%
J9357	Valrubicin injection	1,270.524	1,247.047	-1.8%
J9358	Inj fam-trastu deru-nxki 1mg	31.262	32.874	+5.2%
J9359	Inj lon tesirin-lpyl 0.075mg	221.493	226.608	+2.3%
J9360	Vinblastine sulfate inj	5.152	5.608	+8.9%
J9370	Vincristine sulfate 1 mg inj	8.113	9.529	+17.5%
J9380	Inj teclistamab cqyv 0.5 mg	34.501	35.323	+2.4%
J9381	Inj teplizumab mzwv 5 mcg	38.394	39.217	+2.1%
J9382	Inj zenocutuzumab-zbco 1 mg	33.567	33.863	+0.9%
J9390	Vinorelbine tartrate inj	4.974	4.29	-13.8%
J9395	Injection, fulvestrant	4.938	5.277	+6.9%
J9400	Inj, ziv-aflibercept, 1mg	8.608	8.674	+0.8%
J9601	Inj linvoseltamab-gcpt 1 mg	99.502	99.305	-0.2%
P9045	Albumin (human), 5%, 250 ml	53.077	53.079	0.0%
P9046	Albumin (human), 25%, 20 ml	21.231	21.33	+0.5%
P9047	Albumin (human), 25%, 50ml	53.077	53.324	+0.5%
Q0167	Dronabinol 2.5mg oral	1.645	1.869	+13.6%
Q2041	Axicabtagene ciloleucel car+	531,849.118	562,500.892	+5.8%
Q2042	Tisagenlecleucel car-pos t	614,180.808	611,693.171	-0.4%
Q2043	Sipuleucel-t auto cd54+	56,269.192	55,932.427	-0.6%
Q2050	Doxorubicin inj 10mg	71.861	116.605	+62.3%
Q2053	Brexucabtagene car pos t	489,290.601	510,103.919	+4.3%
Q2054	Lisocabtagene mara car pos t	562,260.836	579,570.614	+3.1%
Q2055	Idecabtagene vicleucel car	559,781.081	567,977.78	+1.5%
Q2056	Ciltacabtagene car-pos t	588,494.808	587,977.755	-0.1%
Q2057	Afamitresgene autoleucel	770,620.00	813,967.375	+5.6%
Q4081	Epoetin alfa, 100 units esrd	0.73	0.688	-5.8%
Q5099	Inj ustekinumab-stba, 1 mg	3.074	3.075	0.0%
Q5100	Inj ustekinumab-kfce, 1 mg	3.214	3.29	+2.4%
Q5103	Injection, inflectra	26.035	27.71	+6.4%
Q5104	Injection, renflexis	26.803	26.615	-0.7%
Q5105	Inj retacrit esrd on dialysi	0.788	0.797	+1.1%
Q5106	Inj retacrit non-esrd use	7.883	7.968	+1.1%
Q5107	Inj mvasi 10 mg	23.735	24.533	+3.4%
Q5108	Injection, fulphila	79.498	67.024	-15.7%
Q5111	Injection, udenyca 0.5 mg	135.889	149.133	+9.7%
Q5112	Inj ontruzant 10 mg	29.808	20.989	-29.6%
Q5113	Inj herzuma 10 mg	56.019	54.942	-1.9%
Q5114	Inj ogivri 10 mg	35.783	31.945	-10.7%
Q5115	Inj truxima 10 mg	31.278	34.563	+10.5%
Q5116	Inj., trazimera, 10 mg	10.425	13.033	+25.0%
Q5117	Inj., kanjinti, 10 mg	56.379	60.522	+7.3%
Q5118	Inj., zirabev, 10 mg	25.854	25.889	+0.1%
Q5119	Inj ruxience, 10 mg	13.686	16.16	+18.1%
Q5120	Inj pegfilgrastim-bmez 0.5mg	119.637	132.096	+10.4%
Q5121	Inj. avsola, 10 mg	28.04	30.83	+10.0%
Q5122	Inj, nyvepria	133.311	136.911	+2.7%
Q5123	Inj. riabni, 10 mg	20.257	18.533	-8.5%
Q5124	Inj. byooviz, 0.1 mg	70.904	240.972	+239.9%
Q5127	Inj, stimufend, 0.5 mg	158.257	143.673	-9.2%
Q5129	Inj, vegzelma, 10 mg	34.654	23.647	-31.8%
Q5130	Inj, fylnetra, 0.5 mg	112.133	105.109	-6.3%
Q5133	Inj, tofidence, 1 mg	5.259	5.013	-4.7%
Q5134	Inj, tyruko, 1 mg	24.321	24.494	+0.7%
Q5135	Inj, tyenne, 1 mg	4.436	4.056	-8.6%
Q5136	Inj. denosumab-bbdz, 1 mg	27.914	27.665	-0.9%
Q5138	Inj, wezlana, iv, 1 mg	4.544	2.354	-48.2%
Q5146	Inj, hercessi, 10 mg	37.865	32.46	-14.3%
Q5147	Inj, aflibercept-ayyh, 1 mg	821.396	803.255	-2.2%
Q5148	Inj, nyposi 1 mcg	1.028	1.034	+0.6%
Q5151	Inj, eculizumab-aagh, 2 mg	31.928	31.778	-0.5%
Q5152	Inj, eculizumab-aeeb, 2 mg	41.789	41.167	-1.5%
Q5156	Inj, tocilizumab-anoh, 1 mg	4.635	4.692	+1.2%
Q5157	Inj, denosumab-bmwo, 1 mg	26.209	25.979	-0.9%
Q5158	Inj, denosumab-bnht, 1 mg	29.797	28.818	-3.3%
Q5162	Inj, denosumab-nxxp, 1 mg	15.841	15.66	-1.1%
Q9950	Inj sulf hexa lipid microsph	18.12	18.126	0.0%
Q9956	Inj octafluoropropane mic,ml	39.956	40.854	+2.2%
Q9957	Inj perflutren lip micros,ml	39.956	40.854	+2.2%
Q9965	Locm 100-199mg/ml iodine,1ml	1.155	0.75	-35.1%
Q9991	Buprenorph xr 100 mg or less	1,996.557	2,068.155	+3.6%
Q9992	Buprenorphine xr over 100 mg	1,996.557	2,068.155	+3.6%
Q9997	Ustekinumab-ttwe iv inj 1 mg	4.531	8.552	+88.7%
Q9998	Inj ustekinumab-aekn, 1 mg	11.138	10.529	-5.5%
Q9999	Inj ustekinumab-aauz 1 mg	13.293	13.154	-1.0%

Codes added and deleted this quarter

New in the July 2026 file (10)

J0681Inj ceftobipole medocarl 3mg
J7674Methacholine chloride, neb
J9053Inj belantamab mafodot blmf
J9062Inj amivantamab 5mg hyaluron
J9161Inj denileuk difti-cxdl 1mcg
J9174Inj, docetaxel (beizray) 1mg
J9232Inj docetaxel (hospira) 1 mg
Q0234Inj, tocilizumab-bavi, 1mg
Q5098Inj ustekinumab-srlf, 1 mg
Q5160Inj, jobevne, 10 mg

Dropped from the file (8)

J0565Inj, bezlotoxumab, 10 mg
J7314Inj., yutiq, 0.01 mg
J9196Inj gemcitabine hcl (accord)
J9295Injection, necitumumab, 1 mg
J9296Inj pemetrexed (accord) 10mg
J9318Inj romidepsin non-lyo 0.1mg
Q5126Inj alymsys 10 mg
Q5128Inj, cimerli, 0.1 mg

Why payment limits move

What is the CMS ASP pricing file?

The CMS ASP pricing file — officially renamed the Medicare Part B Drug Payment Limit File in January 2026 — is the quarterly list of payment allowance limits for provider-administered Part B drugs, computed from manufacturer-reported Average Sales Price data. For most drugs the limit is ASP plus 6%; some codes are priced at 106% of WAC or 95% of AWP instead. It is the price basis a Medicare Administrative Contractor pays buy-and-bill claims on.

Why do payment limits lag the market by two quarters?

By statute, each quarter's limits are computed from manufacturer ASP reports two quarters back — the July 2026 file reflects Q1 2026 sales. When a biosimilar launches or a price war starts, your acquisition cost moves immediately but the payment limit follows six months later. That lag, in both directions, is where buy-and-bill margin is made and lost.

Is reimbursement really ASP plus 6%?

On paper. Medicare pays 80% of the allowable and the 2% budget sequester is applied to that federal share, which works out to an effective add-on of roughly 4.3% rather than 6% when the full allowable is collected. On thin-margin drugs the difference decides whether the drug is profitable at all.

What is a preliminary versus a final file?

CMS typically posts each quarter's file a few weeks before the quarter starts, sometimes marked preliminary, then replaces it with a final version. CMS also restates already-published quarters retroactively. Figures on this page are labeled with the file version they came from, and the whole archive is re-pulled from CMS on every refresh so restatements are picked up.

CMS revised a prior quarter's file — do MACs reprocess old claims?

Not automatically. CMS's quarterly transmittals instruct contractors not to search and adjust claims that have already been processed unless the claims are brought to their attention. If a restated file moved a limit in your favor, the lookback is on you — identify the affected claims and request the adjustment.

What are the NOC pricing file and the NDC-HCPCS crosswalk?

Each quarterly release has companions: the Not Otherwise Classified (NOC) pricing file prices drugs billed under miscellaneous codes, and the NDC-HCPCS crosswalk maps package-level NDCs to billing codes and units. This page tracks the payment-limit file; the companions are linked from the same CMS page. A drug missing from the file is not necessarily non-covered — the MAC may determine a payment limit case by case (42 CFR §414.904).

How do the IRA's negotiated prices (MFP) show up in this file?

Starting January 2026, sales at the negotiated Maximum Fair Price flow into the ASP calculation for the first negotiated drugs, and CMS displays MFP-based limits for selected drugs in the file — part of why some 2026 limits stepped down sharply. The first Part B-selected drugs (Botox, Cimzia, Orencia and Entyvio among the IPAY-2028 list) get MFP-based payment limits in 2028, with prices announced by November 30, 2026.

Why do some codes swing 80% or more in one quarter?

The violent moves are almost always structural: a biosimilar family repricing after launch (the ustekinumab wave in the April 2026 file), a generic price war reaching the ASP basis, a new code transitioning from WAC-based to ASP-based pricing, or — new in 2026 — MFP-priced sales entering the ASP calculation. Multiple-source drugs also substitute pricing when a quarter moves more than 10% (42 CFR §414.904). The leaderboard exists to surface exactly these events the week the file drops.

Full modeling details, source hierarchy, and limitations are on our methodology page. Errors are logged and dated on the public corrections & changelog. For a billing-reference view of any drug (dosing, modifiers, admin CPTs), see the CareCost Estimate drug library.

Quarter archive

Every quarterly file since Q1 2005, diffed against its predecessor. 86 quarter-pairs and counting.

Show all 86 quarters

File	Limits changed	Biggest decrease	Biggest increase
July 2026	690	J3489 -89.1%	J1740 +398.6%
April 2026	666	J1456 -94.4%	J1240 +742.5%
January 2026	659	J1240 -85.1%	J0841 +371.2%
October 2025	763	J9323 -98.8%	J9394 +705.8%
July 2025	756	Q4170 -90.7%	Q4160 +472.0%
April 2025	698	Q4184 -87.2%	J0744 +153.4%
January 2025	685	J2404 -85.7%	J9294 +315.0%
October 2024	686	J2311 -80.6%	J9394 +332.4%
July 2024	673	J1817 -67.7%	Q0167 +219.2%
April 2024	636	J9052 -99.7%	J0285 +304.5%
January 2024	652	J9185 -65.2%	Q4252 +143.2%
October 2023	632	J8521 -94.9%	J9394 +3106.3%
July 2023	623	J9297 -81.1%	J8521 +1453.0%
April 2023	606	J9393 -80.1%	Q4248 +739.9%
January 2023	552	J3105 -89.7%	J9200 +3122.7%
October 2022	541	J1020 -67.7%	J3105 +299.4%
July 2022	530	J2274 -48.4%	J1200 +88.3%
April 2022	524	J1050 -76.2%	J0280 +88.5%
January 2022	519	J3415 -49.3%	J2150 +84.1%
October 2021	520	J8521 -66.3%	J1160 +155.3%
July 2021	526	J0583 -43.4%	J7500 +233.1%
April 2021	519	J3105 -61.5%	J1200 +66.7%
January 2021	522	J9218 -50.3%	J7331 +310.0%
October 2020	510	J1627 -81.4%	J9209 +248.1%
July 2020	509	J9245 -64.9%	J1160 +140.9%
April 2020	499	J9209 -69.5%	Q4115 +193.1%
January 2020	492	J1800 -77.9%	J0287 +46.5%
October 2019	481	J7311 -98.3%	J1800 +588.9%
July 2019	469	J7509 -69.9%	J9218 +283.1%
April 2019	456	J2274 -53.8%	J3000 +380.5%
January 2019	445	J3000 -76.5%	J1245 +94.7%
October 2018	453	J0895 -60.7%	Q0166 +174.6%
July 2018	448	J1670 -38.5%	Q4112 +406.3%
April 2018	441	J1160 -64.0%	J7631 +1061.3%
January 2018	436	Q0167 -45.1%	J1556 +84.1%
October 2017	440	J2503 -30.8%	J3410 +301.2%
July 2017	433	J1742 -65.8%	J2780 +342.5%
April 2017	430	J2700 -76.3%	J9000 +104.7%
January 2017	422	Q0162 -96.2%	Q0167 +274.7%
October 2016	435	J1800 -74.2%	J9200 +224.4%
July 2016	432	J9200 -65.7%	Q0167 +348.0%
April 2016	419	J0698 -75.1%	J2501 +102.2%
January 2016	417	J1160 -96.0%	J9218 +126.2%
October 2015	426	J1742 -54.7%	J1160 +396.6%
July 2015	426	J1160 -81.6%	J1110 +197.7%
April 2015	424	J1940 -65.5%	J1160 +1230.5%
January 2015	414	J8700 -32.3%	J0630 +417.0%
October 2014	431	J2270 -35.3%	J1800 +238.5%
July 2014	423	J2270 -64.8%	J7608 +162.0%
April 2014	430	Q0166 -33.6%	J0600 +649.1%
January 2014	423	J9263 -49.7%	J3070 +397.6%
October 2013	436	J7500 -79.2%	J9050 +396.8%
July 2013	429	J2260 -58.5%	J2370 +203.8%
April 2013	421	J9263 -73.2%	Q0166 +160.7%
January 2013	418	J1160 -70.9%	J1940 +220.0%
October 2012	420	J0670 -83.4%	J0697 +422.8%
July 2012	416	J0697 -68.6%	J0364 +455.9%
April 2012	417	J1270 -52.9%	J2560 +626.5%
January 2012	400	J1160 -80.3%	J1020 +118.5%
October 2011	407	J1626 -45.3%	J1160 +207.3%
July 2011	410	J9351 -52.3%	J2370 +138.4%
April 2011	419	J9211 -60.4%	J9225 +140.3%
January 2011	407	J9178 -79.5%	J2597 +137.5%
October 2010	432	J0735 -68.5%	J1631 +409.6%
July 2010	436	J9206 -62.6%	J8515 +132.6%
April 2010	435	P9043 -63.1%	J0600 +145.6%
January 2010	424	J9206 -48.3%	J1840 +116.8%
October 2009	434	J3430 -71.3%	J0580 +88.3%
July 2009	432	J9178 -62.2%	J9100 +124.7%
April 2009	435	J0300 -45.0%	J9178 +118.0%
January 2009	412	J7631 -82.4%	J2680 +191.6%
October 2008	437	J9206 -50.5%	J7310 +165.2%
July 2008	437	Q0166 -63.4%	J1190 +94.7%
April 2008	425	Q2009 -77.3%	J0800 +170.4%
January 2008	395	Q0179 -50.6%	J0800 +408.4%
October 2007	421	J0698 -57.6%	J3430 +515.8%
July 2007	425	J2405 -85.3%	J0698 +118.8%
April 2007	413	J0456 -46.0%	J2300 +69.0%
January 2007	393	J0744 -41.3%	J0697 +393.9%
October 2006	399	P9045 -71.0%	J9230 +81.8%
July 2006	405	J3486 -64.3%	J9120 +1868.1%
April 2006	403	J1160 -74.0%	J7350 +423.0%
January 2006	370	J3470 -64.9%	J2800 +165.4%
October 2005	404	J9190 -54.8%	J7624 +66.9%
July 2005	427	J7681 -100.0%	J7658 +297.5%
April 2005	397	J9094 -61.5%	J3150 +108.1%

Cite this page.CareCost Optimizer, “ASP Pricing File July 2026: Every Part B Payment-Limit Change,” carecostoptimizer.com/resources/margin-watch/asp-pricing-changes. Computed from the public-domain CMS ASP pricing files. Free to cite with attribution.

Drug economics as of Q3 2026 (Medicare ASP basis)

Maintained by the CareCost Data Desk — full sourcing, parsing, and verification practices documented there. The pipeline re-pulls the complete CMS archive each quarter; corrections are logged on the changelog.

690 limits moved. How many are in your top 20?

The leaderboard is the national change. The practice X-Ray runs this same file against your drug mix, payer book, and acquisition costs — and prices the quarter’s hit in dollars.

Run your practice X-Ray